Re: Is patient travel distance associated with survival on phase II clinical trials in oncology?

Disease specific productivity of american cancer hospitals. PLoS One (2015) 0.75

Is patient travel distance associated with survival on phase II clinical trials in oncology? J Natl Cancer Inst (2003) 3.09

Selection bias, phase II trials, and the FDA accelerated approval process. J Natl Cancer Inst (2003) 1.12

Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07

New equations to estimate GFR in children with CKD. J Am Soc Nephrol (2009) 11.48

Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet (2002) 5.60

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49

Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain (2005) 4.27

Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Stat Med (2007) 3.96

Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol (2006) 3.84

Thirdhand tobacco smoke: emerging evidence and arguments for a multidisciplinary research agenda. Environ Health Perspect (2011) 3.69

HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis (2007) 3.56

Pelvic floor disorders 5-10 years after vaginal or cesarean childbirth. Obstet Gynecol (2011) 3.25

Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med (2009) 3.24

Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis (2004) 2.77

Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol (2013) 2.64

Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA (2007) 2.59

Secondhand tobacco smoke in public places in Latin America, 2002-2003. JAMA (2004) 2.53

Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS (2005) 2.48

Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS (2005) 2.42

Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study. AIDS (2008) 2.19

Cigarette smoking and nocturnal sleep architecture. Am J Epidemiol (2006) 2.19

Pelvic muscle strength after childbirth. Obstet Gynecol (2012) 2.13

Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies. Stat Med (2004) 2.04

Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int (2012) 1.93

Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). Crit Care Med (2009) 1.82

Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease. Arch Intern Med (2002) 1.75

The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). Pain Med (2007) 1.70

Cause-specific mortality among HIV-infected individuals, by CD4(+) cell count at HAART initiation, compared with HIV-uninfected individuals. AIDS (2014) 1.66

Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med (2003) 1.62

Extracellular volume and glomerular filtration rate in children with chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.57

Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol (2002) 1.48

ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Pflugers Arch (2006) 1.47

Specific mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci U S A (2004) 1.45

Non-specific effects of diphtheria tetanus pertussis vaccination on child mortality in Cebu, The Philippines. Int J Epidemiol (2007) 1.45

Spirometry for chronic obstructive pulmonary disease case finding in primary care? Am J Respir Crit Care Med (2005) 1.44

Optimizing iohexol plasma disappearance curves to measure the glomerular filtration rate in children with chronic kidney disease. Kidney Int (2010) 1.39

Epidemiology, public health, and the rhetoric of false positives. Environ Health Perspect (2009) 1.37

Bioavailability of Sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prev Res (Phila) (2011) 1.37

Pelvic floor disorders after vaginal birth: effect of episiotomy, perineal laceration, and operative birth. Obstet Gynecol (2012) 1.31

Second-hand tobacco smoke in public places in urban and rural China. Tob Control (2007) 1.23

Healthcare use by varied highly active antiretroviral therapy (HAART) strata: HAART use, discontinuation, and naivety. AIDS (2004) 1.22

Validation of creatinine assays utilizing HPLC and IDMS traceable standards in sera of children. Pediatr Nephrol (2008) 1.20

Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend (2003) 1.15

Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China. Cancer Prev Res (Phila) (2013) 1.14

Commentary: Call me on my mobile phone...or better not?--a look at the INTERPHONE study results. Int J Epidemiol (2010) 1.14

Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology (2004) 1.13

Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. J Pain (2013) 1.13

Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes. Am J Trop Med Hyg (2007) 1.13

Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis (2011) 1.12

The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol (2010) 1.12

Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus). PLoS One (2009) 1.12

Universal GFR determination based on two time points during plasma iohexol disappearance. Kidney Int (2011) 1.09

Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001. Drug Alcohol Depend (2006) 1.08

Inference for mutually exclusive competing events through a mixture of generalized gamma distributions. Epidemiology (2010) 1.06

The relationship of mental and behavioral disorders to all-cause mortality in a 27-year follow-up of 4 epidemiologic catchment area samples. Am J Epidemiol (2013) 1.06

Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf (2009) 1.04

Strategies for chemoprevention of liver cancer. Eur J Cancer Prev (2002) 1.04

Power spectral analysis of EEG activity during sleep in cigarette smokers. Chest (2007) 1.03

Use of area under the curve to characterize transmission potential after antimalarial treatment. Am J Trop Med Hyg (2006) 1.03

Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias. Am J Epidemiol (2011) 1.02

Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol Drug Saf (2005) 1.01

Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin. Mutat Res (2003) 0.99

Associations between individual and contextual factors and smoking in 13,293 Mexican students. Am J Prev Med (2005) 0.99

Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users. AIDS (2004) 0.99

Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs. Clin Infect Dis (2007) 0.99

Survival benefit of liver transplantation and the effect of underlying liver disease. Surgery (2009) 0.97

Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients. Carcinogenesis (2003) 0.96

The economic impact of exposure to secondhand smoke in Minnesota. Am J Public Health (2009) 0.95

Longitudinal changes in overactive bladder and stress incontinence among parous women. Neurourol Urodyn (2014) 0.93

Determinants of salivary cotinine level: a population-based study in Brazil. Rev Saude Publica (2007) 0.92

An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride). Drug Alcohol Depend (2003) 0.92

Rosuvastatin: an independent analysis of risks and benefits. MedGenMed (2006) 0.91

Longitudinal formulas to estimate GFR in children with CKD. Clin J Am Soc Nephrol (2009) 0.89

The role of the epidemiologist in clinical and translational science. Ann Epidemiol (2006) 0.89

Methods for characterizing differences in longitudinal glomerular filtration rate changes between children with glomerular chronic kidney disease and those with nonglomerular chronic kidney disease. Am J Epidemiol (2011) 0.89

Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C. PLoS One (2012) 0.88

Bimodal virological response to antiretroviral therapy for HIV infection: an application using a mixture model with left censoring. J Epidemiol Community Health (2006) 0.86

Assessing the effect of interventions in the context of mixture distributions with detection limits. Stat Med (2005) 0.86

Hormone replacement therapy and breast carcinoma risk in Hispanic and non-Hispanic women. Cancer (2002) 0.85

Respiratory health equality in the United States. The American thoracic society perspective. Ann Am Thorac Soc (2014) 0.84

Vaginal parity and pelvic organ prolapse. J Reprod Med (2010) 0.84

Survival attributable to an exposure. Stat Med (2009) 0.84

Multilevel competing risks in the evaluation of nosocomial infections: time to move on from proportional hazards and even from hazards altogether. Crit Care (2014) 0.82

Improved estimation of the distribution of suppressed plasma HIV-1 RNA in men receiving effective antiretroviral therapy. J Acquir Immune Defic Syndr (2012) 0.81

Reaching and educating the global tobacco control community: innovative approaches to tobacco control training. Public Health Rep (2006) 0.81

Health and air quality: directions for policy-relevant research. J Toxicol Environ Health A (2003) 0.81

A novel approach to prediction of mild obstructive sleep disordered breathing in a population-based sample: the Sleep Heart Health Study. Sleep (2010) 0.81

Variability of HIV-1 RNA before AIDS and highly active antiretroviral therapy. AIDS (2003) 0.81

Epinephrine-induced hyperpolarization of islet cells without KATP channels. Am J Physiol Endocrinol Metab (2003) 0.80

Acceleration to death from liver cancer in people with hepatitis B viral mutations detected in plasma by mass spectrometry. Cancer Epidemiol Biomarkers Prev (2007) 0.80

Summary of the workshop on methodologies for environmental public health tracking of air pollution effects. Air Qual Atmos Health (2009) 0.80

Virologic and immunologic values allowing safe deferral of antiretroviral therapy. AIDS (2002) 0.80

Joint hypermobility, obstetrical outcomes, and pelvic floor disorders. Int Urogynecol J (2012) 0.79

Hepatitis B virus serum profiles in injection drug users and rates of immunization over time in Barcelona: 1987-2006. Drug Alcohol Depend (2010) 0.79

Membranous glomerulonephritis in the Iberian lynx (Lynx pardinus). Vet Immunol Immunopathol (2007) 0.78

Causal Inference Methods for Estimating Long-Term Health Effects of Air Quality Regulations. Res Rep Health Eff Inst (2016) 0.78

Workshop on lung disease and the environment: where do we go from here? Am J Respir Crit Care Med (2003) 0.77

Dietary amelioration of Helicobacter pylori infection: design criteria for a clinical trial. Cancer Epidemiol Biomarkers Prev (2004) 0.76

Determination of serum biochemical reference intervals for the Iberian lynx (Lynx pardinus). Vet J (2008) 0.76

In reply: pelvic muscle. Obstet Gynecol (2013) 0.75

An Official American Thoracic Society Research Statement: Current Understanding and Future Research Needs in Tobacco Control and Treatment. Am J Respir Crit Care Med (2015) 0.75